An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors

NCT02303444 · clinicaltrials.gov ↗

COMPLETED

Status

667

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Neoplasms

Interventions

DRUG: Sorafenib (Nexavar, BAY43-9006)
DRUG: Other Multikinase inhibitors

Sponsor

Bayer